Article Text

Download PDFPDF
Risperidone effectively increases rates of symptomatic remission of acute mania in people with bipolar disorder

Statistics from


  • For correspondence: Srihari Gopal, Forest Research Institute, Harborside Financial Plaza V, Jersey City, NJ 07311, USA; sgopal2{at}

  • Sources of funding: Johnson & Johnson Pharmaceutical Research and Development and National Institute of Health, USA.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.